Barrow Hanley Mewhinney & Strauss LLC Mimedx Group, Inc. Transaction History
Barrow Hanley Mewhinney & Strauss LLC
- $28.2 Billion
- Q2 2025
A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 336 shares of MDXG stock, worth $2,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
336Holding current value
$2,264% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MDXG
# of Institutions
245Shares Held
102MCall Options Held
51.2KPut Options Held
56.8K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$190 Million61.77% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$62.8 Million0.0% of portfolio
-
Trigran Investments, Inc.8.39MShares$56.6 Million9.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.96MShares$46.9 Million0.0% of portfolio
-
Paradigm Capital Management Inc4.45MShares$30 Million1.34% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $766M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...